Thrombotic Microangiopathy After Kidney Pancreas Transplant Managed With Eculizumab and a Calcineurin Inhibitor-free Basiliximab/Belatacept Maintenance Regimen: Between a Rock and a Hard Place.
作者信息
Chen Jeanne M, Yaqub Muhammad S, Jan Muhammad Y, Sharfuddin Asif A, Powelson John A, Lutz Andrew J, Hata Jessica L, Fridell Jonathan A
机构信息
Department of Pharmacy, IU Health, Indianapolis, IN.
Department of Surgery, Indiana University School of Medicine, Indianapolis, IN.
出版信息
Transplant Direct. 2025 Jun 12;11(7):e1825. doi: 10.1097/TXD.0000000000001825. eCollection 2025 Jul.
PMID:40519672
Abstract
摘要
相似文献
[1]
[2]
[3]
[4]
[5]
[6]
[7]
Belatacept for kidney transplant recipients.
Cochrane Database Syst Rev. 2014-11-24
[8]
[9]
Eculizumab in Transplant-Associated Thrombotic Microangiopathy.
Clin Appl Thromb Hemost. 2017-3
本文引用的文献
[1]
Safety and Efficacy of Belatacept in Pancreas Transplantation: A Case Series.
Clin Transplant. 2025-3
[2]
Post-transplant Thrombotic Microangiopathy.
J Am Soc Nephrol. 2025-5-1
[3]
[4]
Belatacept in Pancreas Transplantation: Promising Insights From a Cohort Series.
Transpl Int. 2024-4-16
[5]
[6]
Thrombotic microangiopathy after kidney transplantation: Expanding etiologic and pathogenetic spectra.
World J Transplant. 2024-3-18
[7]
TMA in Kidney Transplantation.
Transplantation. 2023-11-1
[8]
[9]
Contrast-Enhanced Ultrasound Versus Doppler Ultrasound for Detection of Early Vascular Complications of Pancreas Grafts.
AJR Am J Roentgenol. 2020-9-22
Zotero 插件